Vertex aims to further bolster its gene-editing therapy pipeline by using Orna's lipid nanoparticle delivery technologies during the three-year collaboration.

Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 ...

The researcher has given an overview on the regulatory network of extracellular circRNAs in cancer and their impact on cancer drug resistance.

NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services for drug discovery and ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Filed provisional patent application, further expanding IP portfolio ...

We recently published a list of the 12 Best Nanotechnology Stocks to Buy According to Hedge Funds. In this article, we are ...

Nanotechnology, a groundbreaking concept introduced by Nobel Prize-winning physicist Richard Feynman in 1959 during a speech ...

T endons are the small but tough linkers between bones and muscle. When they are injured, repairing a tendon is no small task ...

In recent years, alongside biological cues, significant attention has been paid to the influence of biomechanics on cellular function. Studies have ...

Her team recently developed a small nanocarrier that actively delivers a poly (ADP-ribose) polymerase (PARP) inhibitor and a ...

In collaboration with European counterparts, researchers from Tel Aviv University have introduced a novel dual-drug ...